IMU 2.56% 3.8¢ imugene limited

Ann: Imugene Advances to Phase 2 in Gastric Cancer Trial, page-60

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 9,595 Posts.
    lightbulb Created with Sketch. 330
    Yes super, top line results means the first detailed installment of the final results from the trial - if that makes sense.

    "Top" doesn't refer to good in this case, they can be good or bad.

    But we will get more data. Remember that they are looking for signs of efficacy, which we know they have as patients are producing antibodies.

    The lack of safety issues is stunning. If they just replicate the T cell results then that is enough, as no safety issues makes imu's drug very valuable. But I think they will get better efficacy too imho.
 
watchlist Created with Sketch. Add IMU (ASX) to my watchlist
(20min delay)
Last
3.8¢
Change
-0.001(2.56%)
Mkt cap ! $386.7M
Open High Low Value Volume
3.8¢ 3.9¢ 3.8¢ $134.8K 3.498M

Buyers (Bids)

No. Vol. Price($)
23 1738258 3.8¢
 

Sellers (Offers)

Price($) Vol. No.
3.9¢ 494405 4
View Market Depth
Last trade - 16.10pm 29/11/2024 (20 minute delay) ?
IMU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.